SEPPIC S.A. acquired Serdex from Bayer Aktiengesellschaft (DB:BAYN) on January 1, 2017. Jean-Claude Rivalland, Arnaud de Rochebrune, Xavier Jancène ,Chloé Mau, Claire Toumieux, Alexis Valot and Olivier Picquerey of Allen & Overy LLP acted as advisor to Bayer Aktiengesellschaft while Isabelle Marguet and Magali Stuber of Dechert LLP advised SEPPIC in the deal. Bertrand Dufournier and Pierre Moullade of Arjil & Associés acted as financial advisor and Frédéric Zeitoun and Camille Burnand-Bellon acted as Grant Thornton acted as accountant to SEPPIC. PwC acted as accountant to seller. SEPPIC S.A. completed the acquisition of Serdex from Bayer Aktiengesellschaft (DB:BAYN) on January 1, 2017.